IIT Roorkee Finds Breakthrough To Beat World's Most Dangerous Superbugs
The research team, led by Prof Ranjana Pathania from the Department of Biosciences and Bioengineering, designed a novel molecule, Compound 3b, that works with a potent antibiotic Meropenem. This combination therapy has shown the ability to treat infections caused by Klebsiella pneumoniae, a pathogen designated as a top-priority threat by the World Health Organization (WHO) due to its resistance to multiple drugs.
"This breakthrough offers a promising solution to one of the world's most urgent health challenges," stated Prof. Pathania. "Our compound neutralises the resistance mechanism and shows strong therapeutic results in preclinical models."
Compound 3b is a type of drug that prevents bacteria from using enzymes to destroy antibiotics. The study, which included collaboration with researchers from UiT Tromso in Norway, found the new compound to be highly specific, safe for human cells, and effective at reducing bacterial infection in lung tests on animals.
The discovery of a drug like Compound 3b is a crucial step in a larger fight. Antibiotic resistance is a silent pandemic that makes once-treatable infections, from pneumonia and tuberculosis to common wound infections, lethal again. Without effective antibiotics, many modern medical procedures, including surgery, organ transplants, and cancer chemotherapy, become much more risky.
This research is vital because it addresses a fundamental problem of the bacteria evolving faster than the speed at which new drugs are being developed. By revitalising existing antibiotics, Compound 3b provides a powerful new tool without starting from scratch. It is a strategic victory against a microbial enemy that threatens to unravel decades of medical progress.
"This innovation reflects IIT Roorkee's commitment to developing impactful scientific solutions for global challenges. In the face of rising antibiotic resistance, such research provides critical hope for effective and accessible treatments," said IIT Roorkee director Prof KK Pant.
The findings have been published in the prestigious Journal of Medicinal Chemistry and is expected to be a significant step forward in safeguarding public health from drug-resistant superbugs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
a day ago
- Time of India
IIT Roorkee scientists reveal how this common herb could defeat world's most dangerous superbugs & enhance antibiotic power
A research team at IIT Roorkee has found that a natural compound called thymol may help weaken stubborn superbugs and improve the effectiveness of antibiotics. Thymol is a plant-based substance commonly found in thyme. The study suggests it can target persister cells , bacteria that survive treatment and cause long-lasting infections, especially in Acinetobacter baumannii . This bacterium is known for causing persistent and chronic infections in hospitals. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program The findings, published in the Antimicrobial Agents and Chemotherapy journal, also show that thymol may make powerful antibiotics like meropenem work better. Early results indicate that using thymol alongside meropenem increases the antibiotic's ability to fight infections. This could be a promising way to tackle persistent bacterial infections. Professor Ranjana Pathania, the lead researcher, said, 'Thymol's ability to break down bacterial persistence and boost existing antibiotics offers a hopeful path to address antimicrobial resistance .' Live Events She added, 'By focusing on persister cells, we may improve treatment for chronic and recurring infections.' The research team discovered that thymol attacks persister cells in several ways. It disrupts the bacteria's energy production, making survival harder. It also damages the bacteria's outer membrane, making them more vulnerable. Thymol produces reactive oxygen species (ROS) that stress and weaken bacteria. It also blocks bacterial efflux pumps, which can help antibiotics like meropenem work better. While these findings are encouraging, more research and clinical trials are needed to confirm thymol's use in real medical treatments. Professor K.K. Pant, Director of IIT Roorkee, said, 'Antimicrobial resistance is a major global problem. This study shows how natural compounds could help overcome persistent infections. It reflects our commitment to research that tackles important health challenges.' The next stage of research will focus on improving the thymol and meropenem combination and testing its potential through further studies. If successful in clinical trials, this approach could become a new weapon against antibiotic-resistant infections, the team said. Inputs from agencies
India Today
2 days ago
- India Today
Can a rotten egg cause a Liver Abscess? Find out here
A liver abscess is a localised collection of pus in the liver, often caused by infection. It can develop following injury to the liver or due to infections spreading through the bloodstream, particularly via the portal vein. The most common types are pyogenic (bacterial) and amoebic (parasitic) liver abscesses. Less commonly, fungi or parasites like Echinococcus cause liver cysts that may mimic relatively rare, liver abscesses can be life-threatening if untreated, with significant mortality risk. Early diagnosis and proper management are essential to improve AND RISK FACTORSPyogenic liver abscesses arise from bacterial infections such as E. coli, Klebsiella pneumoniae, Streptococcus, and sources include biliary tract diseases (stones, strictures), cholangitis, appendicitis, diverticulitis, or liver abscess is caused by Entamoeba histolytica, which initially infects the intestines and later spreads to the hydatid cysts caused by Echinococcus granulosus (a tapeworm) lead to liver factors include diabetes, male sex, age 40-60, immunocompromised status, and existing liver or biliary AND SYMPTOMSHigh fever with chills (90% of cases)Right upper abdominal pain or tenderness (50-75%)Shortness of breath or cough (due to diaphragm irritation)Nausea, vomiting, and loss of appetiteJaundice in some patientsWeight loss and fatigueRarely, Klebsiella infections cause septic emboli affecting eyes or brainDIAGNOSTIC APPROACHBlood tests: Elevated white blood cells, liver enzymes, inflammatory markers, and blood cultures to detect Ultrasound is the first step, showing cystic lesions. Contrast-enhanced CT scan offers more detailed For amoebic abscess, antibody testing for Entamoeba histolytica. For hydatid cyst, ELISA for Guided needle aspiration provides pus for culture and organism identification, critical for targeted Percutaneous catheter drainage under ultrasound or CT guidance is preferred for abscesses larger than 5 cm. Smaller abscesses may be treated with needle aspiration Broad-spectrum antibiotics combined with metronidazole for amoebic infection. Treatment ranges from 2 to 6 weeks depending on Reserved for ruptured abscesses, thick-walled or multiple abscesses, or cases refractory to percutaneous therapy: Albendazole for hydatid cysts, with surgery or drainage in complicated STUDY: ANIL DHAWAN'S JOURNEY WITH LIVER ABSCESSAnil Dhawan, a 51-year-old man, experienced high fever and severe shortness of breath, struggling even to get fresh air. Concerned about his worsening condition, he rushed to BLK Kapur Hospital, Rajendra Place. Blood tests revealed a high Total Leukocyte Count (TLC), signalling infection. A CT scan followed by urgent ultrasound detected multiple large abscesses in his liver. The doctor urgently recommended drainage to prevent the abscesses from spreading further. Anil underwent percutaneous drainage with 3 to 4 catheters inserted to slowly evacuate the pus. After 15 days of hospitalisation and antibiotic treatment, Anil recovered well and was discharged. Anil's experience highlights the importance of early recognition, diagnostic imaging, and timely intervention to manage liver abscess ROLE OF THE REGISTERED HEALTH INFORMATION ADMINISTRATOR (RHIA)advertisementManaging liver abscess cases requires coordinated care among multiple healthcare professionals — physicians, radiologists, infectious disease specialists, surgeons, nurses, and pharmacists. The RHIA plays a critical role in:Maintaining accurate, detailed patient records for diagnostics, treatments, and proper coding and documentation for liver abscess cases to support clinical decisions and communication between teams to improve care coordination and patient in data collection for clinical audits and quality improvement related to liver abscess RHIA supports the healthcare team by ensuring information accuracy and availability, which is vital for timely and effective liver abscess AND PRECAUTIONSPractice good hygiene and clean, safe water to avoid parasitic treat abdominal infections and biliary chronic illnesses such as contact with animal feces or saliva to prevent hydatid early medical attention if fever or abdominal pain COMPLICATIONSAbscess rupture leading to peritonitis or septic shockSpread of infection causing septic emboli in lungs, brain, or especially in biliary tract pain or intermittent fever if abscess is walled complications such as liver or kidney failure, thrombosis, or secondary — LIVER ABSCESSQ: What causes a liver abscess?A: Bacterial infections (pyogenic) and parasitic infections like Entamoeba histolytica are the primary causes. Risk factors include biliary disease, diabetes, and immunocompromised status.Q: What are the symptoms?A: High fever, chills, right upper abdominal pain, nausea, vomiting, and sometimes jaundice and shortness of breath.Q: How is it diagnosed?A: Blood tests, ultrasound, CT scans, serology, and needle aspiration of abscess fluid.Q: How is it treated?A: Drainage of abscess plus targeted antibiotics or antiparasitic drugs.Q: Can it be prevented?A: Yes, with good hygiene, safe drinking water, and prompt treatment of abscesses are dangerous infections inside the liver that cause fever, pain, and breathing difficulty. Early diagnosis with ultrasound and CT scan, combined with drainage and antibiotics, leads to recovery.- Ends advertisement
Hans India
2 days ago
- Hans India
Cigarettes, bidis, chewable tobacco continue to silently raise cancer risks in youth: Experts
New Delhi: More than the new and trendy alternatives, traditional tobacco products like cigarettes, bidis, and chewable tobacco are posing a silent crisis for India's youth, significantly raising the risk of cancers like lung, mouth and throat, said health experts on Monday, calling out the need to step up the fight against these to push the fight against tobacco. According to the 2019 Global Youth Tobacco Survey, 8.5 per cent of students aged 13-15 use tobacco, contributing to 1.3 million deaths annually. With tobacco linked to 90 per cent of lung cancer cases, the experts warned that this overlooked epidemic demands immediate action beyond the vaping debate. 'Over 90 per cent of lung cancer cases in India are linked to combustible tobacco. In my clinical experience, I regularly treat patients as young as 17 for tobacco-induced complications. What we need is a calibrated approach that combines prevention, regulation, and public awareness -- not selective panic,' Dr. Narender Saini, Chairman, Antimicrobial Resistance (AMR) Standing Committee, at Indian Medical Association (IMA), told IANS. There is growing concern in the medical community that public discourse on youth addiction is missing the mark. While focus has been on new trends, the experts warned that the silent epidemic of oral and throat cancer among under-25s, linked to traditional tobacco products like gutkha and khaini, is a more urgent and dangerously overlooked crisis. 'The data points to a stark reality -- traditional tobacco's grip on our youth far outweighs other concerns, urging us to rethink our priorities. Our focus must expand from trendy alternatives to the proven killers: cigarettes, bidis, and chewable tobacco,' Dr Chandrakant S Pandav, Padma Shri Awardee, and former Prof and HoD, Community Medicine, AIIMS, New Delhi, told IANS. The global health expert noted that the traditional tobacco landscape remains largely unchallenged in schools and villages. Despite soaring concerns over vaping, combustible and smokeless tobacco products continue to thrive, fuelled by cultural acceptance and unchecked distribution. 'Tobacco use poses immediate and long-term risks to infection control. My clinical experience reveals a stark contrast: tobacco-related illnesses are rampant, while vaping-related lung issues are remarkably rare,' Saini said. The experts called for strengthening school-based interventions, community awareness campaigns, and stricter enforcement of existing laws. 'Bridging the gap between data and policy, stakeholders must now craft a unified strategy that tackles both supply and demand, ensuring young Indians are shielded from every form of tobacco harm,' Pandav added. Dr. Pawan Gupta, Senior Consultant, Pulmonary Medicine at a leading city-based hospital, told IANS that 'the damage inflicted by traditional tobacco begins early and lasts a lifetime". 'We witness its devastating consequences daily -- oral cancers, lung diseases, and heart conditions -- often in individuals who started using these products in their teenage years. With 1.35 million deaths annually, the science is clear: traditional tobacco is a proven killer, and our youth are its most vulnerable targets,' Gupta said.
